Search results
The median survival following diagnosis of ascites was 5.7 months. Ovarian cancer favoured longer survival while low serum albumin, low serum protein and liver metastases adversely affected survival. The independent prognostic factors for survival were cancer type, liver metastases and serum albumin.
26 sie 2021 · As a result, the presence of malignant ascites in advanced-stage ovarian cancer patients is associated with a poor prognosis, warranting the development of more effective treatments for the palliation of malignant ascites.
The management of malignant ascites in ovarian cancer consists of both limiting the development of peritoneal fluid accumulation and addressing its outflow. As therapies for recurrent disease rarely lead to a cure, the therapeutic intent should focus on improving QOL.
Since fewer women have stage 1 or “localized” ovarian cancer, the overall prognosis for regional or distant disease can be broken down by year since diagnosis.
3 maj 2024 · Ascites is the accumulation of fluid in the peritoneal space of the abdomen. Though it can be caused by several non-cancerous conditions, when seen alongside a pelvic mass, ascites is often a sign of peritoneal carcinomatosis, a classic symptom of advanced-stage ovarian cancer. So, what causes ascites? Can it be treated?
8 maj 2020 · The most important factor that influences patient prognosis in ovarian cancer is the resectability of the primary tumour and metastatic deposits—survival is optimal in cases where the cancer is...
In the ROCkeTS study, we aimed to identify the best diagnostic test for ovarian cancer in symptomatic patients, through head-to-head comparisons of risk-prediction models, in a real-world setting. Here, we report the results for the postmenopausal cohort. Methods.
